Venous thrombosis during multimodal treatment of primary breast carcinoma
- PMID: 7248984
Venous thrombosis during multimodal treatment of primary breast carcinoma
Abstract
In a cooperative group study of 433 breast cancer patients treated with 2 years of postmastectomy chemotherapy, 22 (5%) developed venous thromboses of various types. Two patients died. None of the patients had demonstrable tumor metastases at the time of the venous thrombosis, although seven had metastases a median of 11 months after the thromboses. Thirteen living patients have not had tumor recurrences. No patient developed thrombosis after the chemotherapy was completed. It is possible that one or more of the chemotherapeutic agents initiated the clotting problems. Thrombophlebitis is a possible problem occurring during adjuvant chemotherapy for breast cancer and requires prompt treatment.
Similar articles
-
[Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].Strahlenther Onkol. 1995 Jan;171(1):18-28. Strahlenther Onkol. 1995. PMID: 7839301 German.
-
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.J Clin Oncol. 2003 May 1;21(9):1825-35. doi: 10.1200/JCO.2003.09.006. J Clin Oncol. 2003. PMID: 12721260 Clinical Trial.
-
[Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].Strahlenther Onkol. 1994 Aug;170(8):441-52. Strahlenther Onkol. 1994. PMID: 8085210 German.
-
[Chemotherapy of breast cancer].Recenti Prog Med. 1977 Apr;62(4):448-70. Recenti Prog Med. 1977. PMID: 327520 Review. Italian. No abstract available.
-
[Work capacity of patients having undergone radical therapy of breast cancer].Vopr Onkol. 1984;30(5):98-105. Vopr Onkol. 1984. PMID: 6375131 Review. Russian. No abstract available.
Cited by
-
Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.J Angiogenes Res. 2009 Oct 24;1:7. doi: 10.1186/2040-2384-1-7. J Angiogenes Res. 2009. PMID: 20016693 Free PMC article.
-
Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer.Br J Cancer. 2008 Oct 7;99(7):1000-6. doi: 10.1038/sj.bjc.6604620. Epub 2008 Sep 2. Br J Cancer. 2008. PMID: 18766191 Free PMC article.
-
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter.Support Care Cancer. 2007 Oct;15(10):1213-7. doi: 10.1007/s00520-007-0277-0. Epub 2007 Jun 20. Support Care Cancer. 2007. PMID: 17578607
-
A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy.Breast Cancer Res Treat. 1996;40(2):151-9. doi: 10.1007/BF01806210. Breast Cancer Res Treat. 1996. PMID: 8879681 Clinical Trial.
-
Hemostatic alterations in cancer patients.Cancer Metastasis Rev. 1992 Nov;11(3-4):237-48. doi: 10.1007/BF01307180. Cancer Metastasis Rev. 1992. PMID: 1423816 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical